Decentralized Clinical Trials
Essential tips to avoid common pitfalls
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via other means.
Data must not be lost when patients do not come to site for several weeks, data quality must be guaranteed throughout the project, and data must be protected even when patients use their own mobile.
How can the common pitfalls that come with DCTs be avoided?
#1 Avoiding data loss when patients visit frequency is reduced
- Offer Flexibility
- Think Simplicity
#2 Tackling technology adoption risks
- Understand that needs of the technology usersdepend on wide range of criteria
- Work with patients to adjust to their needs
- Develop long-term relationships
- Help study patients understand the study flow
- Train, train, and train!
#3 Securing data quality when collecting data from multiple sources
#4 Ensuring data protection
READ THE FULL WHITE PAPER:
Attend the DMB presentation on “The shift to ePRO collection at home: Strategies To Preserve Data Quality And Re-think Compliance”
Date: November 22Time: 11:15AM CETLocation: Paris, FrancePresentation in French See the full DMB Annual Conference
At Kayentis, we: Make sure everyone has the same expectations for the data Think of
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints
Date: October 18Location: PariSanté Campus in Paris OBJECTIVES: Define decentralized clinical trials, provide an update
Date: September 12Location: San Antonio, Texas Changing the methods of eCOA data collection, requires a
Last update : 18 October 2022